Findings presented at 50th Annual Meeting of ASCO show aromatase inhibitor effective for premenopausal women when combined with ovarian function suppression.
Sandra Kear, OncLive
Advertisement
Articles by Sandra Kear, OncLive
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Closing the Kidney Gap in Cardio-Kidney-Metabolic Care
2
FDA Approves At-Home Starting Dose of Lecanemab for Treatment of Alzheimer Disease
3
AI and Drug Information: Where OpenEvidence Stands Out—and Where Pharmacists Still Win
4
Evaluation of a Pharmacist-Driven Discharge Medication Reconciliation Service
5